background
felin
leukemia
viru
felv
gammaretroviru
domest
cat
discov
half
centuri
ago
cat
infect
felv
may
develop
progress
infect
result
persist
viremia
immunodefici
tumor
anemia
death
signific
number
cat
mount
protect
immun
respons
suppress
viremia
cat
develop
regress
infect
character
absenc
viral
replic
presenc
low
level
provir
dna
biolog
import
latter
proviru
carrier
larg
unknown
demonstr
ten
cat
receiv
transfus
blood
avirem
proviru
carrier
develop
activ
felv
infect
progress
outcom
develop
fatal
felvassoci
diseas
infect
outcom
diseas
spectrum
evolut
felvc
one
cat
mirror
natur
infect
two
cat
develop
persist
antigenemia
six
cat
transient
antigenem
reactiv
infect
occur
cat
one
recipi
develop
nonregen
anemia
associ
felvc
four
other
develop
tcell
lymphoma
one
secondari
lymphoblast
leukemia
five
ten
recipi
cat
receiv
provirusposit
avirem
blood
wherea
five
receiv
provirusand
viral
rnaposit
avirem
blood
notabl
cat
receiv
blood
contain
provir
dna
exhibit
later
onset
graver
outcom
felv
infect
cat
transfus
blood
contain
provir
dna
viral
rna
leukocyt
count
cytokin
analys
indic
immun
system
latter
cat
react
quicker
effici
result
underlin
biolog
epidemiolog
relev
felv
proviru
carrier
risk
inadvert
felv
transmiss
via
blood
transfus
demonstr
replic
capac
provir
dna
uncontrol
immun
system
result
implic
veterinari
medicin
requir
test
blood
donor
blood
product
felv
proviru
sensit
polymeras
chain
reaction
also
gener
interest
reveal
import
latent
retrovir
dna
infect
host
aim
elimin
retrovir
infect
popul
proviru
carrier
must
consid
felin
leukemia
viru
felv
retroviru
occur
worldwid
domest
cat
relat
small
felid
felv
infect
induc
cytoprolif
tumor
cytosuppress
immunodefici
anemia
diseas
fatal
outcom
felv
isol
categor
sever
subgroup
accord
viral
receptor
usag
interfer
capabl
felva
common
subgroup
horizont
transmit
highli
contagi
low
pathogen
felva
infect
cat
may
develop
diseas
lymphoma
mainli
tcell
origin
felvb
felvc
aris
within
felva
infect
cat
recombin
endogen
felvlik
sequenc
enfelv
via
mutat
insert
surfac
glycoprotein
gene
respect
felvb
found
felvinfect
cat
wherea
felvc
develop
felv
infect
strongli
associ
develop
nonregen
anemia
furthermor
felvt
tcell
tropic
cytopath
viru
caus
lymphoid
deplet
immunodefici
may
develop
felva
infect
cat
via
mutat
insert
surfac
glycoprotein
gene
final
recent
felvd
subgroup
describ
felvd
recombin
virus
aris
transduct
envelop
gene
felin
endogen
gammaretroviru
ervdc
felv
varieti
outcom
felv
infect
influenc
strain
subtyp
dose
viru
also
differ
host
factor
age
immun
system
statu
infect
cat
spectrum
differ
infect
outcom
classifi
accord
result
felv
antigen
nucleic
acid
detect
serolog
abort
regress
progress
atyp
infect
detect
antigen
paramet
viremia
cat
addit
latent
nonproduct
infect
character
absenc
viremia
persist
viru
bone
marrow
identifi
cat
follow
regress
infect
latent
infect
detect
prolong
cultiv
bone
marrow
cell
presenc
hydrocortison
usual
resolv
within
month
exposur
felv
detect
cat
month
infect
although
persist
infect
cat
fail
develop
success
immun
respons
felv
succumb
felvassoci
diseas
cat
regress
infect
previous
also
refer
recov
cat
mount
cellular
humor
immun
respons
felv
overcom
viremia
usual
week
howev
cat
typic
remain
provirusposit
remaind
live
preval
proviru
posit
cat
vari
among
differ
investig
popul
observ
high
clinic
import
proviru
posit
statu
complet
understood
may
contribut
longlast
mainten
protect
immun
felv
howev
reactiv
infect
develop
felvassoci
diseas
document
mani
proviru
posit
cat
felv
transmit
horizont
mainli
via
saliva
persist
infect
cat
also
vertic
infect
queen
kitten
viru
also
detect
fece
urin
milk
blood
iatrogen
transmiss
felv
may
occur
via
transfus
blood
felv
virem
antigenposit
blood
donor
blood
recipi
may
particularli
prone
infect
felvassoci
diseas
due
preexist
grave
clinic
condit
possibl
immunosuppress
common
reason
blood
transfus
cat
includ
hemorrhag
lack
erythropoiesi
immunemedi
hemolyt
anemia
blood
bank
cat
develop
demand
highqual
blood
product
increas
screen
blood
donor
product
infecti
diseas
increas
import
commonli
recommend
test
felin
blood
donor
felv
infect
antigen
detect
far
risk
felv
transmiss
transfus
proviru
posit
blood
evalu
howev
intraderm
inocul
plasmid
deoxyribonucl
acid
dna
carri
felva
proviru
rickardfra
result
product
felv
infect
therefor
hypothes
whole
blood
contain
white
blood
cell
carri
felv
proviru
transfer
infect
result
fullblown
infect
recipi
cat
aim
present
studi
thu
test
whether
felv
infect
transmit
via
transfus
blood
felv
proviru
posit
antigen
neg
blood
donor
recipi
cat
test
whether
felv
infect
transmit
transfus
proviru
posit
blood
specifi
pathogenfre
spf
kitten
transfus
ml
blood
five
kitten
group
receiv
blood
provirusposit
cat
dp
five
kitten
group
b
receiv
blood
provirusand
viral
rnaposit
cat
dr
five
cat
control
group
c
receiv
blood
spf
cat
dn
tabl
three
blood
donor
cat
test
felvneg
viru
isol
neg
antigen
blood
sampl
collect
recipi
prior
week
weekli
interv
transfus
week
blood
transfus
advers
reaction
observ
recipi
accord
felv
load
transfus
blood
cat
group
receiv
total
proviru
copi
recipi
group
b
receiv
proviru
viral
rna
copi
pack
cell
volum
pcv
cat
dr
time
point
blood
collect
transfus
valu
use
calcul
viral
rna
load
per
ml
whole
blood
describ
method
section
recipi
cat
group
b
becam
felvinfect
blood
transfus
judg
provir
polymeras
chain
reaction
pcr
peripher
blood
plasma
viral
rna
detect
revers
transcriptas
rt
pcr
fig
contrast
cat
control
group
c
remain
felvneg
throughout
studi
cat
group
b
receiv
blood
proviru
viral
rna
becam
felv
provirusposit
significantli
earlier
cat
group
receiv
blood
proviru
week
post
transfus
cat
group
b
alreadi
proviru
posit
wherea
none
cat
group
posit
p
fisher
fig
b
first
week
transfus
provir
load
significantli
higher
group
b
group
fig
b
p
mwu
contrast
week
provir
load
significantli
lower
cat
group
b
group
p
mwu
fig
b
recipi
cat
group
b
also
turn
plasma
viral
rnaposit
fig
plasma
viral
rna
load
significantli
higher
cat
group
b
compar
group
week
post
transfus
p
mwu
fig
howev
cat
group
b
exhibit
lower
plasma
viral
rna
load
cat
group
significantli
lower
week
p
mwu
week
post
transfus
three
cat
group
b
exhibit
undetect
plasma
viral
rna
load
wherea
cat
group
remain
posit
ethylenediaminetetraacet
acid
edta
anticoagul
plasma
sampl
also
analyz
presenc
felv
antigen
marker
viremia
sandwich
enzymelink
immunosorb
assay
elisa
recipi
cat
group
test
time
point
transfus
fig
two
five
cat
group
becam
persist
infect
progress
infect
three
cat
develop
transient
viremia
regress
infect
fig
five
cat
group
b
develop
regress
infect
three
transient
viremia
low
valu
max
two
undetect
antigenemia
fig
four
week
post
transfus
significantli
cat
group
group
b
p
fisher
fig
analyz
load
cat
group
exhibit
significantli
higher
load
week
transfus
cat
group
b
p
mwu
fig
peripher
blood
collect
week
post
transfus
test
presenc
replic
viru
use
tabl
outcom
felv
infect
two
felvexpos
blood
donor
ten
expos
recipi
cat
viru
isol
assay
cell
cultur
two
progress
infect
cat
group
cat
test
posit
fig
wherea
recipi
test
neg
moreov
bone
marrow
collect
week
post
transfus
test
cell
cultur
presenc
high
dose
hydrocortison
replic
viru
latent
bone
marrow
infect
detect
six
recipi
cat
four
group
two
group
b
fig
shed
felv
viral
rna
investig
use
rtpcr
saliva
sampl
collect
week
prior
transfus
week
post
transfus
saliva
viral
rna
detect
recipi
cat
group
b
particularli
high
rna
load
two
cat
progress
infect
detail
see
tabl
addit
file
tabl
antibodi
felv
detect
plasma
sampl
use
three
differ
elisa
fig
total
antifelv
whole
viru
unglycosyl
envelop
surfac
protein
transmembran
protein
recipi
cat
group
b
develop
antibodi
felv
extent
fig
lowest
antibodi
level
observ
two
persist
infect
cat
group
fig
antibodi
respons
earlier
higher
cat
group
b
cat
group
week
transfus
four
five
cat
group
b
total
antifelv
antibodi
level
posit
control
wherea
one
five
cat
group
surpass
whole
viru
antibodi
assay
fig
neg
provir
load
provid
provir
copiescel
cat
group
b
felv
proviru
detect
significantli
earlier
week
cat
group
p
fisher
cat
group
b
significantli
higher
provir
load
week
lower
load
week
p
mwu
indic
asterisk
plasma
viral
rna
load
provid
copiesml
plasma
cat
group
b
significantli
higher
viral
rna
load
week
lower
load
week
p
mwu
indic
asterisk
cat
group
c
neg
test
time
point
data
shown
group
b
none
cat
group
present
antibodi
posit
control
fig
h
p
fisher
cat
group
b
also
exhibit
significantli
higher
antibodi
level
cat
group
week
post
transfus
p
mwu
antibodi
remain
low
two
persist
virem
cat
moreov
cat
transient
antibodi
detect
level
posit
control
fig
end
observ
period
week
post
transfus
two
persist
virem
cat
group
display
low
antibodi
level
whole
viru
wherea
cat
regress
infect
display
high
antibodi
level
fig
dissect
confirm
antibodi
respons
sampl
cat
collect
week
blood
donor
cat
collect
time
blood
collect
transfus
analyz
western
blot
fig
none
cat
display
notabl
band
strong
band
confirm
cat
group
b
except
two
persist
virem
cat
addit
band
cat
becam
strong
week
cat
overcom
viremia
limit
respons
observ
cat
group
b
blood
donor
cat
dr
time
blood
collect
transfus
none
cat
group
c
donor
cat
dn
present
antibodi
felv
endogen
felvlik
sequenc
consid
potenti
confound
experiment
felv
infect
enfelv
proviru
load
determin
peripher
blood
sampl
recipi
three
blood
donor
collect
prior
blood
transfus
use
three
quantit
pcr
assay
cat
group
tend
somewhat
lower
enfelvenv
total
load
cat
group
b
extent
statist
signific
p
mwu
enfelvenv
p
mwu
p
mwu
total
signific
differ
observ
enfelv
load
recipi
group
b
compar
control
cat
group
c
blood
donor
cat
p
kw
enfelv
load
pleas
see
figur
addit
file
figur
character
immun
respons
blood
transfus
felv
infect
detail
transcript
level
cytokin
determin
edtaanticoagul
blood
week
blood
transfus
fig
assess
potenti
respons
felin
interleukin
measur
determin
potenti
respons
also
quantifi
tumor
necrosi
assess
proinflammatori
cytokin
wherea
exhibit
antiinflammatori
effect
pronounc
upregul
observ
level
cat
group
b
increas
compar
pretransfus
level
level
chang
significantli
time
three
group
p
f
b
p
f
c
p
f
significantli
higher
level
week
compar
week
fig
increas
observ
level
signific
chang
time
three
group
p
f
b
p
f
c
p
f
significantli
higher
level
group
b
week
compar
week
fig
signific
differ
level
among
three
group
observ
week
p
kw
significantli
higher
level
group
b
group
p
upregul
observ
antiinflammatori
compar
pretransfus
level
signific
chang
time
observ
group
significantli
western
blot
analysi
use
plasma
sampl
week
week
post
transfus
first
five
strip
incub
posit
control
pool
immun
cat
monoclon
antibodi
respect
neg
control
pool
felvneg
cat
character
respect
viral
protein
cat
dp
dr
dn
indic
b
cat
indic
rightpoint
triangl
denot
band
expect
length
sampl
test
assay
condit
ninefold
respect
fig
signific
chang
time
observ
group
c
p
f
higher
level
week
compar
week
p
week
signific
differ
observ
among
three
group
level
p
kw
proinflammatori
signific
chang
time
observ
group
b
p
f
lost
signific
posttest
signific
chang
time
also
observ
group
p
f
c
p
f
significantli
higher
level
week
compar
week
group
significantli
higher
level
week
compar
week
group
c
p
fig
signific
differ
among
group
observ
week
p
kw
week
p
kw
significantli
lower
level
group
compar
group
b
time
point
p
signific
differ
three
group
signific
chang
time
observ
transcript
level
fig
minor
upregul
observ
fig
week
post
transfus
weekli
clinic
examin
perform
veterinarian
two
cat
group
virem
one
cat
group
b
exhibit
elev
bodi
temperatur
transfus
week
week
week
respect
two
cat
group
present
anorexia
mild
lethargi
episod
day
treatment
meloxicam
intraven
fluid
two
cat
recov
lymphadenomegali
mandibular
cervicali
superficiali
poplit
lymph
node
observ
five
cat
group
four
five
cat
group
b
lymphadenomegali
distinct
persist
cat
group
group
b
none
cat
group
c
develop
elev
bodi
temperatur
lymphadenomegali
addit
detail
pleas
see
tabl
addit
file
tabl
complet
hematolog
perform
edtaanticoagul
blood
sampl
collect
recipi
cat
prior
blood
transfus
weekli
thereaft
week
addit
clinic
chemistri
perform
sera
week
appear
clinic
sign
accord
increas
age
cat
median
pcv
cat
group
b
c
significantli
increas
time
b
p
f
week
p
c
p
f
week
p
see
also
addit
file
figur
decreas
pcv
observ
sever
cat
group
onset
antigenemia
approxim
week
post
transfus
decreas
result
significantli
lower
pcv
group
compar
group
c
week
post
transfus
p
mwu
white
blood
cell
wbc
count
significantli
chang
time
group
b
p
f
follow
sever
decreas
wbc
count
cat
week
lowest
valu
observ
refer
rang
age
signific
rebound
observ
week
p
see
also
addit
file
figur
slowest
recoveri
wbc
count
observ
cat
also
overcam
antigenemia
latest
time
point
within
group
b
temporari
decreas
result
significantli
lower
wbc
count
cat
group
b
compar
cat
control
group
c
week
p
mwu
group
wbc
count
also
decreas
post
transfus
cat
simultan
transient
antigenem
cat
rebound
wbc
count
observ
start
week
wherea
limit
late
increas
wbc
count
start
week
observ
two
cat
progress
infect
neutrophil
granulocyt
count
signific
chang
time
observ
group
p
f
lost
signific
posttest
data
shown
lowest
neutrophil
count
sever
intermitt
neutropenia
observ
persist
infect
cat
count
low
refer
rang
age
signific
chang
time
observ
lymphocyt
count
group
b
p
f
group
c
see
also
addit
file
figur
cat
group
b
exhibit
decreas
lymphocyt
count
week
post
transfus
similar
decreas
also
observ
week
later
cat
group
week
three
cat
overcam
antigenemia
similar
cat
group
b
week
post
transfus
moder
hyperproteinemia
moder
hypoalbuminemia
detect
cat
group
immedi
cat
overcom
antigenemia
fig
develop
high
level
antibodi
felv
fig
serum
protein
electrophoresi
reveal
moder
hyperbetaglobulinemia
sever
polyclon
hypergammaglobulinemia
compat
chronic
immun
stimul
data
shown
initi
observ
period
week
blood
transfus
cat
remain
facil
regularli
examin
hematolog
blood
chemistri
analys
perform
routin
week
week
post
transfus
cat
group
b
develop
reactiv
felv
infect
blood
level
see
also
euthan
due
sever
dyspnea
tabl
upon
necropsi
multicentr
lymphoma
thymu
mesenter
lymph
node
liver
bone
marrow
observ
secondari
lymphoblast
leukemia
wbc
lymphoblast
see
also
addit
file
figur
histopatholog
immunohistolog
examin
reveal
tcell
lymphoma
week
post
transfus
cat
group
b
euthan
pleural
effus
upon
necropsi
multicentr
tcell
lymphoma
thymu
kidney
lumbar
lymph
node
observ
tabl
cat
test
time
death
week
persist
infect
cat
group
euthan
sever
normocyticnormochrom
nonregen
anemia
moder
leukopenia
due
moder
neutropenia
time
euthanasia
antigen
load
felvc
typic
associ
develop
nonregen
anemia
felvinfect
cat
detect
subgroup
pcr
see
also
addit
file
figur
addit
felvb
detect
aris
mani
cat
felva
infect
week
persist
virem
cat
euthan
sever
dyspnea
caus
pleural
effus
cat
vaccin
reexpos
felv
list
followup
studi
cytolog
examin
pleural
effus
reveal
numer
lymphat
blast
total
nucleat
cell
count
addit
cat
exhibit
moder
lymphopenia
moder
hypoproteinemia
moder
increas
alkalin
phosphatas
activ
slight
hypochloremia
cat
increas
week
necropsi
reveal
multicentr
tcell
lymphoma
thymu
pericardium
tonsil
prescapular
lymph
node
cat
group
exhibit
hyperproteinemia
polyclon
hypergammaglobulinemia
week
infect
subsequ
develop
felin
lower
urinari
tract
diseas
flutd
week
transfus
undergo
intens
care
outsid
barrier
facil
small
anim
clinic
vetsuiss
faculti
cat
place
privat
complet
recoveri
week
post
transfus
cat
group
euthan
due
clinic
deterior
persist
anorexia
apathi
cat
exhibit
anisocoria
week
test
indic
reactiv
infect
valu
increas
subsequ
time
euthanasia
sampl
collect
prior
euthanasia
viral
rnaposit
upon
necropsi
multicentr
tcell
lymphoma
thymu
liver
observ
tabl
remain
four
ten
felv
expos
recipi
cat
control
cat
group
c
remain
healthi
time
point
write
manuscript
week
blood
transfus
blood
donor
cat
group
b
cat
dr
group
cat
dp
confirm
latent
felv
infect
judg
bone
marrow
cell
cultur
presenc
high
dose
hydrocortison
week
blood
collect
blood
transfus
week
experiment
felv
exposur
time
point
cat
dr
demonstr
reactiv
felv
infect
blood
level
see
also
list
clinic
cat
exhibit
sever
dyspnea
pleural
effus
upon
necropsi
multicentr
tcell
lymphoma
thymu
inguin
lymph
node
identifi
tabl
blood
donor
group
cat
dp
remain
clinic
healthi
week
blood
collect
transfus
week
felv
exposur
result
demonstr
first
time
felv
infect
transmit
recipi
via
transfus
blood
felv
proviru
carrier
blood
collect
transfus
week
blood
donor
expos
felv
contain
low
proviru
load
approxim
proviru
copi
within
ml
blood
suffici
result
product
felv
infect
recipi
young
cat
select
experi
suscept
felv
infect
adult
cat
although
increas
suscept
young
cat
may
immatur
immun
system
increas
suscept
felv
may
also
expect
blood
transfus
recipi
sever
clinic
condit
possibl
immunosuppress
moreov
transfus
volum
ml
adjust
bodi
weight
kitten
kg
time
transfus
reflect
volum
regular
blood
transfus
adult
cat
usual
ml
cat
kg
bodi
weight
thu
chosen
experiment
setup
may
well
mirror
situat
field
adult
blood
transfus
recipi
recipi
cat
subsequ
develop
felvassoci
diseas
confirm
hypothesi
whole
blood
contain
white
blood
cell
carri
felv
proviru
transfer
viru
result
fullblown
infect
recipi
cat
result
confirm
extend
previou
result
felv
infect
transmit
subcutan
inject
plasmid
carri
provir
dna
addit
product
infect
intramuscular
intraderm
inject
plasmid
carri
provir
dna
report
felin
immunodefici
viru
cat
simian
immunodefici
viru
macaqu
studi
provid
direct
biolog
relev
clinic
import
conclud
immin
risk
felv
transmiss
via
blood
transfus
provirusposit
blood
must
consid
clinic
perform
commonli
use
blood
donor
screen
assay
detect
antigen
felvinfect
blood
donor
use
current
studi
would
recogn
risk
therefor
highli
recommend
screen
felin
blood
donor
blood
product
felv
antigen
also
felv
proviru
use
sensit
pcr
proviru
peripher
blood
blood
donor
replicationcompet
month
initi
viru
exposur
howev
viral
replic
suppress
blood
donor
immun
system
undetect
level
cell
contain
proviru
enter
new
suscept
host
via
blood
transfus
viral
replic
reignit
unabl
determin
data
whether
reignit
primarili
absenc
prepar
immun
system
recipi
cat
also
mix
lymphocytetyp
reaction
result
blastogenesi
donor
lymphocyt
felv
express
contribut
fast
onset
viral
replic
reaction
would
expect
occur
within
hour
day
blood
transfus
blood
sampl
collect
time
point
eg
lymphocyt
isol
flow
cytometri
analysi
lymphocyt
popul
cytokin
measur
one
week
transfus
earliest
time
point
analyz
increas
total
lymphocyt
number
observ
cat
group
c
contrast
cat
group
b
exhibit
decreas
lymphocyt
count
support
hypothesi
mix
lymphocyt
reaction
therefor
one
assum
felv
activ
suppress
blood
donor
immun
system
recipi
immun
mechan
predominantli
involv
control
felv
replic
insuffici
transfer
via
blood
transfus
latter
would
true
cellular
immun
respons
demonstr
previous
cellular
immun
respons
play
import
role
suppress
viral
replic
felv
infect
replic
compet
proviru
corrobor
one
felvexpos
blood
donor
dr
present
reactiv
infect
develop
multicentr
lymphoma
month
blood
collect
transfus
second
provirusposit
cat
serv
blood
donor
group
cat
dp
remain
healthi
clinic
unremark
week
initi
studi
although
blood
result
progress
infect
two
recipi
cat
felvassoci
fatal
diseas
three
recipi
cat
dp
remain
provirusposit
low
proviru
load
studi
necessari
analyz
immun
respons
provirusposit
longterm
survivor
success
keep
replic
compet
viru
check
felv
infect
observ
cat
group
b
resembl
natur
felv
infect
regard
clinic
find
laboratori
chang
infect
outcom
diseas
spectrum
felv
subgroup
evolv
infect
cat
exhibit
elev
bodi
temperatur
lymphadenomegali
anorexia
lethargi
chang
hematolog
paramet
includ
anemia
neutropenia
sever
clinic
sign
associ
sever
infect
lymphadenomegali
particularli
pronounc
two
virem
cat
group
natur
felv
infect
character
leukopenia
lymphopenia
variabl
degre
anemia
decreas
wbc
lymphocyt
count
also
observ
present
studi
felvexpos
cat
control
cat
decreas
wbc
degre
lymphocyt
count
appear
directli
associ
initi
felv
infect
onset
viral
replic
furthermor
cat
recov
quickli
antigenemia
exhibit
fast
rebound
wbc
count
addit
cat
group
exhibit
adequ
increas
pcv
observ
control
cat
relat
increas
age
cat
replic
virus
detect
cell
cultur
blood
bone
marrow
latter
presenc
high
dose
hydrocortison
six
recipi
cat
group
b
confirm
replic
capac
felv
six
cat
infect
via
blood
transfus
contain
provir
dna
viral
rna
addit
eight
recipi
cat
regress
infect
develop
antibodi
felv
indic
presenc
least
minim
viral
replic
cat
contrast
persist
infect
cat
exhibit
lower
antibodi
level
previous
describ
natur
experiment
felv
infect
cat
incident
antibodi
detect
cat
western
blot
viru
prepar
use
blot
produc
cell
harbor
felvabc
mainli
c
practic
reason
consider
higher
yield
wherea
cat
present
studi
expos
felva
felva
c
exhibit
antigenet
differ
moreov
may
also
denatur
antigen
prepar
boil
sd
potenti
result
loss
threedimension
structur
lack
antibodi
bind
sampl
avail
viru
neutral
assay
present
studi
consist
earlier
data
cat
regress
infect
develop
antibodi
quit
unlik
antibodi
interf
detect
antigen
cat
sera
contain
strong
antibodi
reactiv
felv
interfer
antigen
detect
supposedli
high
affin
monoclon
antibodi
use
elisa
subsequ
five
ten
recipi
cat
succumb
felvassoci
diseas
cat
suffer
nonregen
anemia
tcell
lymphoma
leukemia
commonli
regard
felvassoci
diseas
final
appear
nonregen
anemia
associ
emerg
felvc
result
also
parallel
natur
felvinfect
develop
felvc
felva
via
mutat
describ
felvinfect
cat
suffer
nonregen
anemia
cat
receiv
blood
contain
provir
dna
group
exhibit
later
onset
graver
outcom
felv
infect
compar
cat
transfus
blood
contain
provir
dna
also
viral
rna
group
b
initi
cat
group
b
becam
provirusposit
significantli
earlier
transfus
develop
significantli
higher
viral
rna
provir
load
cat
group
howev
sever
week
transfus
cat
group
exhibit
significantli
higher
viral
rna
provir
antigen
load
compar
group
b
moreov
cat
group
antigenposit
compar
group
b
two
cat
group
none
group
b
develop
persist
infect
cat
group
b
none
group
becam
viral
rnaneg
within
observ
period
possibl
explan
observ
could
effici
detect
felv
immun
system
cat
group
b
presenc
viral
rna
higher
provir
dna
load
transfus
blood
compar
group
group
low
load
proviru
hidden
within
donor
cell
present
differ
viral
load
parallel
variat
leukogram
mark
decreas
wbc
lymphocyt
count
observ
cat
group
b
week
cat
group
test
viral
rna
posit
moreov
week
post
transfus
cat
particularli
cat
group
b
high
level
maximum
increas
observ
play
critic
role
innat
adapt
immun
viral
infect
partial
direct
inhibitori
effect
viral
replic
primarili
immun
stimulatori
modulatori
effect
cellular
defens
mechan
felvspecif
immun
import
role
specif
cytotox
lymphocyt
demonstr
felvspecif
effector
cytotox
tcell
respons
detect
earli
week
viru
exposur
cours
earli
infect
particularli
high
cat
recov
viremia
furthermor
cat
group
b
exhibit
higher
level
compar
group
week
transfus
howev
chang
cytokin
much
less
pronounc
key
regul
humor
immun
promot
differenti
cell
wherea
produc
cell
stimul
b
cell
antibodi
secret
level
increas
cat
group
week
moder
increas
level
observ
group
b
around
week
wherea
group
level
detect
week
multipl
effect
also
associ
b
cell
prolifer
antibodi
product
accordingli
cat
high
antifelv
antibodi
level
observ
group
b
group
week
viru
exposur
altogeth
data
indic
immun
system
cat
group
b
react
quicker
pronounc
transfus
blood
viru
transmit
blood
compar
cat
group
result
support
assumpt
effici
detect
felv
recipi
blood
blood
donor
b
viral
rna
higher
provir
load
present
addit
factor
result
differ
viral
load
felv
exposur
may
load
enfelv
present
cell
cat
interindividu
differ
associ
enfelv
load
felv
replic
report
previous
cat
high
enfelv
load
exhibit
higher
viral
replic
cat
low
enfelv
load
earli
phase
persist
felv
infect
moreov
low
enfelv
load
prior
felv
exposur
may
significantli
associ
develop
progress
infect
wherea
cat
high
enfelv
load
may
rather
develop
regress
infect
cat
present
studi
origin
spf
catteri
recipi
cat
assign
three
group
avoid
famili
cluster
nonetheless
cat
group
tend
somewhat
lower
enfelv
load
cat
group
b
would
outlin
fit
lower
felv
replic
observ
earli
infect
higher
number
cat
develop
progress
infect
group
compar
group
b
reactiv
felv
infect
observ
three
cat
present
studyon
blood
donor
cat
dr
donor
group
b
two
recipi
cat
group
b
group
emphas
biolog
epidemiolog
import
provirusposit
cat
support
recommend
test
cat
suspect
expos
felv
pcr
identifi
felv
proviru
carrier
subsequ
reactiv
proviru
posit
cat
pose
infect
risk
cat
addit
hand
cat
reactiv
infect
develop
fatal
felvassoci
diseas
thu
detect
proviru
carrier
eg
decreas
felv
incid
felin
popul
cat
exposur
risk
test
felv
antigenemiaviremia
also
felv
proviru
plasma
viral
rna
could
also
detect
recipi
cat
prior
reactiv
support
hypothesi
presenc
plasma
viral
rna
may
associ
higher
probabl
reactiv
felv
infect
therefor
detect
plasma
viral
rna
proviru
posit
avirem
cat
may
serv
marker
potenti
reactiv
recipi
cat
shed
viral
rna
saliva
vari
degre
post
transfus
high
load
saliva
viral
rna
primarili
note
virem
cat
felv
rna
also
observ
cat
regress
infect
confirm
previou
observ
earli
infect
saliva
viral
rna
may
good
marker
antigenemiaviremia
contrast
longterm
infect
cat
sinc
introduct
sensit
molecular
method
occurr
cat
felv
provir
dna
absenc
antigenemia
viremia
well
document
provirusposit
cat
describ
among
swiss
cat
popul
result
studi
underlin
biolog
epidemiolog
relev
retrovir
proviru
felv
avirem
cat
support
observ
provir
dna
cat
regress
infect
may
maintain
replic
capac
mani
month
year
sensit
pcr
recommend
detect
proviru
carrier
demonstr
current
studi
perform
cat
serv
blood
donor
exclud
inadvert
transmiss
felv
blood
recipi
also
gener
decreas
incid
felv
infect
within
cat
popul
felv
vaccin
current
avail
efficaci
prevent
persist
infect
develop
diseas
subsequ
viru
exposur
howev
vaccin
prevent
proviru
integr
ideal
futur
vaccin
develop
also
prevent
proviru
integr
moreov
viral
erad
treatment
develop
elimin
provir
dna
infect
host
latter
also
goal
envis
hiv
human
total
spf
cat
liberti
research
waverli
ny
usa
includ
studi
three
adult
male
castrat
spf
cat
serv
blood
donor
eightweekoldmal
spf
kitten
serv
blood
transfus
recipi
tabl
recipi
cat
randomli
assign
three
group
five
cat
avoid
famili
cluster
group
compris
cat
origin
cat
id
group
b
compris
cat
origin
cat
id
group
c
compris
cat
origin
cat
id
two
three
adult
blood
donor
dp
dr
origin
cat
id
experiment
expos
previous
describ
list
previou
studi
cat
undergon
regress
infect
undetect
antigenemia
test
time
point
blood
transfus
collect
week
infect
third
blood
donor
dn
origin
cat
id
adult
spf
cat
cat
maintain
separ
group
confin
univers
facil
barrier
condit
optim
etholog
hygien
condit
previous
describ
experi
perform
accord
swiss
law
offici
approv
veterinari
offic
canton
zurich
prior
start
experi
cat
clinic
examin
blood
plasma
sampl
conjunctiv
oropharyng
rectal
swab
collect
verifi
cat
spf
statu
sampl
test
absenc
felv
felin
immunodefici
viru
hemoplasma
parvoviru
caliciviru
herpesviru
coronaviru
bartonella
hensela
chlamydophila
feli
previous
describ
addit
serum
sampl
test
antibodi
felin
caliciviru
felin
herpesviru
felin
parvoviru
immunofluoresc
assay
previous
describ
cat
neg
test
infect
upon
arriv
kitten
adapt
new
environ
care
person
week
train
relax
handl
blood
collect
without
anesthesia
blood
transfus
ml
blood
collect
three
adult
blood
donorsdp
dr
dnunder
intramuscular
anesthesia
mgkg
ketamin
narketan
ag
belp
switzerland
mg
kg
midazolam
dormicum
roch
pharma
ag
reinach
switzerland
blood
collect
syring
contain
ml
anticoagul
citrat
phosphat
dextros
adenin
fenwal
lake
zurich
il
usa
blood
donor
divid
five
syring
mlone
syring
per
recipi
cat
donor
cat
administ
ml
ringerlact
solut
freseniu
kabi
stan
switzerland
monitor
recoveri
anesthesia
kitten
receiv
ml
anticoagul
whole
blood
age
week
blood
cat
group
felv
provirusposit
copiesml
blood
plasma
viral
rnaand
donor
dp
blood
cat
proviru
copiesml
blood
plasma
viral
rnaposit
copiesml
plasma
donor
dr
blood
cat
felv
proviru
viral
rnaand
donor
dn
prior
transfus
blood
type
donor
recipi
cat
determin
use
commerci
immunochromatograph
test
lab
test
b
alvedia
franc
moreov
standard
salineagglutin
crossmatch
procedur
perform
blood
recipi
correspond
blood
donor
cat
blood
type
recipi
cat
compat
donor
crossmatch
kitten
anesthet
intramuscularli
describ
ml
whole
blood
collect
baselin
analysi
prevent
circulatori
volum
overload
thereaft
ml
blood
respect
blood
donor
transfus
slowli
min
recipi
cat
blood
transfus
kitten
monitor
advers
reaction
gener
condit
cat
monitor
daili
recipi
cat
castrat
week
transfus
wbc
count
complet
hemogram
perform
use
sysmex
sysmex
corpor
kobe
japan
blood
smear
stain
use
autom
stain
instrument
hematek
siemen
switzerland
differenti
count
perform
microscop
case
sever
anemia
manual
reticulocyt
count
perform
use
standard
method
base
brilliant
cresyl
blue
sigmaaldrich
steinheim
germani
stain
blood
smear
clinic
chemistri
analyz
use
coba
integra
system
roch
diagnost
rotkreuz
switzerland
week
appear
clinic
sign
serum
biochemistri
analysi
includ
bilirubin
glucos
blood
urea
nitrogen
creatinin
protein
albumin
cholesterol
alkalin
phosphatas
aspart
aminotransferas
alanin
aminotransferas
lipas
sodium
chlorid
potassium
phosphoru
calcium
level
serum
protein
electrophoresi
perform
one
cat
hyperproteinemia
week
cat
group
use
semiautom
agaros
gel
electrophoresi
system
previous
describ
determin
provir
load
dna
extract
buffi
coat
obtain
ml
edtaanticoagul
blood
use
qiaamp
blood
kit
qiagen
hombrechtikon
switzerland
elut
buffer
determin
plasma
viral
rna
load
total
nucleic
acid
tna
extract
edta
plasma
use
magna
pure
lc
total
nucleic
acid
isol
kit
roch
diagnost
elut
buffer
determin
viral
rna
load
saliva
swab
process
use
phosphatebuff
salin
previous
describ
determin
cytokin
transcript
level
edtaanticoagul
blood
mix
immedi
blood
collect
mrna
lysi
buffer
mrna
isol
kit
roch
diagnost
frozen
previous
describ
mrna
purifi
use
mrna
isol
kit
magna
pure
lc
instrument
roch
diagnost
elut
buffer
firststrand
complementari
dna
cdna
synthes
use
highcapac
cdna
revers
transcript
kit
appli
biosystem
rotkreuz
switzerland
duplic
sampl
extract
neg
control
consist
phosphat
buffer
salin
extract
parallel
monitor
crosscontamin
felv
proviru
load
quantifi
taqman
pcr
target
uniqu
region
long
termin
repeat
felv
previous
describ
use
tna
taqman
fast
univers
pcr
master
mix
appli
biosystem
assay
amplifi
three
felv
subgroup
b
c
enfelv
lower
limit
detect
assay
one
proviru
copi
per
reaction
thermocycl
condit
follow
initi
denatur
follow
cycl
proviru
load
normal
felin
albumin
copi
number
use
taqman
pcr
previous
describ
number
felv
provir
copi
ml
transfus
blood
calcul
use
extract
elut
pcr
volum
copiespcr
measur
pcr
tna
plasma
saliva
analyz
taqman
rtpcr
target
region
proviru
pcr
previous
describ
use
tna
superscript
iii
platinum
onestep
quantit
rtpcr
system
invitrogen
basel
switzerland
lower
limit
detect
assay
viral
rna
copi
per
reaction
plasma
viral
rna
load
calcul
number
copi
per
millilit
blood
number
viral
rna
copi
ml
transfus
blood
calcul
use
pcv
number
copiesml
plasma
determin
rtpcr
pcr
rtpcr
assay
run
abi
fast
realtim
pcr
system
appli
biosystem
neg
posit
extract
control
includ
run
enfelv
proviru
load
determin
peripher
blood
sampl
collect
prior
blood
transfus
use
quantit
realtim
taqman
pcr
assay
abi
fast
realtim
pcr
system
appli
biosystem
previous
describ
follow
enfelv
target
measur
enfelvenv
total
copi
number
calcul
addit
copi
number
proviru
load
normal
felin
albumin
copi
number
use
taqman
pcr
previous
describ
edtaanticoagul
plasma
sampl
analyz
presenc
doubleantibodi
sandwich
elisa
use
monoclon
antibodi
three
epitop
region
previous
describ
antibodi
felv
whole
viru
determin
elisa
use
felv
per
well
purifi
sucros
gradient
cell
cultur
supernat
cell
chronic
infect
felv
previous
describ
antibodi
recombin
transmembran
protein
recombin
nonglycosyl
form
surfac
glycoprotein
measur
elisa
previous
describ
result
calcul
percentag
defin
posit
control
run
test
sampl
reach
posit
control
consid
posit
elisa
addit
antibodi
felv
determin
western
blot
use
felv
per
blot
purifi
sucros
gradient
cell
cultur
supernat
previous
describ
edtaanticoagul
plasma
sampl
dilut
peroxidas
conjug
goatanticat
antibodi
jackson
immunoresearch
laboratori
inc
pa
dilut
primari
inhous
monoclon
mous
ascit
antibodi
dilut
secondari
peroxidas
conjug
goatantimous
antibodi
jackson
immunoresearch
laboratori
dilut
use
posit
control
moreov
pool
edta
plasma
sampl
immun
spf
cat
use
posit
neg
control
respect
serolog
analysi
possibl
lack
sampl
volum
week
heparin
plasma
sampl
avail
test
felv
neutral
activ
donor
recipi
cat
viru
isol
peripher
blood
lithium
heparinanticoagul
sampl
collect
recipi
week
post
transfus
viru
isol
perform
use
lithium
heparin
plasma
cell
previous
describ
cell
monitor
daili
cytopath
effect
day
cell
cultur
supernat
collect
quantif
antigen
elisa
detect
latent
infect
bone
marrow
aspir
collect
proxim
humeru
recipi
cat
week
post
transfus
blood
donor
week
blood
collect
transfus
week
infect
gener
anesthesia
analgesia
previous
describ
bone
marrow
collect
ml
rpmi
cell
cultur
medium
sigmaaldrich
buch
switzerland
mm
lglutamin
uml
penicillin
streptomycin
invitrogen
fc
bioconcept
allschwil
switzerland
crandel
felin
kidney
crfk
cell
cellsml
cultur
plate
tpp
techno
plastic
product
ag
trasadingen
switzerland
confluenc
cell
confirm
felvneg
pcr
bone
marrow
cell
resuspend
medium
cocultur
crfk
cell
cell
medium
concurr
cultur
plate
cell
cultur
medium
contain
follow
rpmi
mc
coy
sigmaaldrich
mm
lglutamin
uml
penicillin
streptomycin
fc
ml
hydrocortison
sigmaaldrich
cultur
maintain
week
half
medium
replac
everi
day
supernat
collect
elisa
felv
rtpcr
develop
nonregen
anemia
felvinfect
cat
typic
associ
emerg
felvc
therefor
one
cat
euthan
nonregen
anemia
felv
subgroup
investig
blood
plasma
bone
marrow
collect
time
necropsi
felvaspecif
primer
felvbspecif
primer
felvcspecif
primer
use
convent
pcr
previous
describ
quantifi
cytokin
level
peripher
blood
realtim
pcr
primer
probe
use
previous
describ
except
primer
probe
design
revers
primer
anneal
exonexon
junction
reaction
contain
forward
revers
primer
probe
cytokin
assay
perform
use
taqman
fast
univers
pcr
master
mix
appli
biosystem
initi
denatur
follow
cycl
vabl
abelson
murin
leukemia
viral
oncogen
homolog
abl
zeta
polypeptid
ywhaz
transcript
level
serv
refer
gene
normal
previous
describ
calcul
rel
transcript
level
perform
use
genorm
version
sever
sampl
transcript
level
total
n
week
total
n
week
total
n
week
detect
limit
realtim
pcr
sampl
avail
cytokin
measur
week
six
cat
dr
tabl
euthan
human
reason
underw
necropsi
histopatholog
examin
tissu
section
lymphoma
test
identifi
b
cell
use
tcell
marker
dako
bcell
marker
dako
labvis
thermo
fisher
scientif
fremont
usa
statist
analys
perform
use
graphpad
prism
window
version
graphpad
softwar
san
diego
ca
usa
chang
time
group
differ
time
point
test
use
wilcoxon
sign
rank
test
pair
sampl
p
w
friedman
test
multipl
sampl
p
f
dunn
posttest
p
multipl
adjust
pvalu
comparison
famili
comparison
comput
frequenc
compar
use
fisher
exact
test
p
fisher
differ
group
b
compar
use
mannwhitney
utest
p
mwu
differ
three
group
test
use
kruskalw
test
p
kw
pvalu
consid
statist
signific
